Browsing: monitor

Chronic kidney disease (CKD) is the fifth leading cause of mortality in the United States and is associated with an elevated risk of cardiovascular disease. Enhanced education and access to home urine tests can help patients more effectively manage their CKD, reducing patients’ risks, according to research presented at the American Association of Nurse Practitioners…

July 14 (Reuters) – Potential signs of frailty in older adults taking Eli Lilly’s GLP-1 obesity drug Zepbound may signal relatively high risks for adverse outcomes, according to a large study that underscores concerns about how best to monitor seniors as U.S. Medicare expands access to GLP-1 therapies